| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.01T | 1.84T | 1.65T | 1.38T | 682.71B |
| Gross Profit | 1.45T | 1.02T | 904.00B | 708.84B | 240.19B |
| EBITDA | 373.53B | 311.29B | 279.60B | 205.33B | -75.11B |
| Net Income | 137.60B | 107.04B | 95.53B | 34.42B | -177.55B |
Balance Sheet | |||||
| Total Assets | 3.20T | 2.79T | 2.65T | 2.52T | 2.38T |
| Cash, Cash Equivalents and Short-Term Investments | 1.01T | 749.03B | 713.87B | 639.25B | 494.23B |
| Total Debt | 875.92B | 896.02B | 887.29B | 925.50B | 928.46B |
| Total Liabilities | 1.86T | 1.78T | 1.70T | 1.66T | 1.53T |
| Stockholders Equity | 1.29T | 975.06B | 909.95B | 816.29B | 799.74B |
Cash Flow | |||||
| Free Cash Flow | 186.12B | 85.94B | 138.84B | 169.10B | -268.61B |
| Operating Cash Flow | 388.55B | 375.92B | 356.91B | 286.59B | -107.30B |
| Investing Cash Flow | -193.28B | -286.90B | -199.06B | -116.43B | -167.20B |
| Financing Cash Flow | 61.13B | -53.52B | -94.03B | -28.48B | 356.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥1.15T | 11.48 | 11.50% | 3.11% | 9.13% | 29.20% | |
68 Neutral | ¥1.33T | 9.92 | ― | 1.97% | 12.26% | 11.58% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥568.17B | 11.80 | 13.92% | 1.50% | 4.11% | -30.52% | |
62 Neutral | ¥1.27T | 52.49 | 11.29% | 3.00% | 8.07% | 15.81% | |
50 Neutral | ¥7.23B | 3.59 | ― | ― | 4.42% | -93.47% |